The University of Chicago Header Logo

Connection

Ayman Al-Hendy to Receptors, LHRH

Back to Details
This is a "connection" page, showing publications Ayman Al-Hendy has written about Receptors, LHRH.
Ayman Al-Hendy
Connection Strength
0.056
Receptors, LHRH
  1. Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials. Lancet. 2022 09 17; 400(10356):896-907.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.